-
Working Toward the End of Cancer Health DisparitiesAACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.
by Eric Fitzsimmons
-
September 16: The Week In Cancer NewsAir pollution research provides clues to how cancer starts, and KRAS-targeting drug appears to keep cancer at bay longer than standard of care, but questions remain
by Marci A. Landsmann
-
Chemotherapy Linked to Hearing Loss in AdultsGet your hearing checked periodically if you will be undergoing chemotherapy with neurotoxic effects.
by Sandra Gordon
-
September 9: The Week in Cancer NewsEarly-onset cancer is increasing globally, and testing population-wide preventive DNA testing.
by Kevin McLaughlin
-
September 2: The Week in Cancer NewsFertility preservation does not impact outcomes for breast cancer patients, and ultraprocessed foods linked to increased risk of colorectal cancer in men.
by Thomas Celona
-
The View From a CAR T-Cell Clinical TrialAfter exhausting her treatment options, Ellen Reich got CAR T-cell treatment for multiple myeloma through a clinical trial.
by Pamela Rafalow Grossman
-
August 26: The Week in Cancer NewsAdvanced cervical cancer rates are rising despite prevention and screening tools, and CAR T-cell therapy inaccessible to many across the country.
by Eric Fitzsimmons
-
August 19: The Week in Cancer NewsLink found between fracking wells and leukemia in children, and accurate reporting of cancer outcomes urged for Native Hawaiians and Pacific Islanders.
by Kevin McLaughlin
-
August 12: The Week in Cancer NewsDrug for HER2-positive cancer receives further approvals, and researchers study the risk of lung cancer from wildfires.
by Marci A. Landsmann
-
August 5: The Week in Cancer NewsStudy finds majority of patients treated with chemotherapy experience hearing loss, and ‘rogue’ online pharmacies found to be dispensing oncology drugs.
by Thomas Celona
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
